EMJ GOLD: Pharma Marketing, Medical & More podcast

Artwork

Business Alice Watson Marketing Medicalaffairs Pharma Pharmaceuticalinnovation Pharmainnovation Pharmatech Podcasting Education Patientcentric Pharmaceutical

Player FM - Internet Radio Done Right

Vor drei Jahren hinzugefügt

Inhalt bereitgestellt von Alice Watson. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Alice Watson oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

<

<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/ask-grumpy">Ask Grumpy</a></span>

<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/ask-grumpy">Ask Grumpy</a></span> podcast artwork

<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/ask-grumpy">Ask Grumpy</a></span> podcast artwork

1
Ask Grumpy

vor 1 dayvor 1d ago

Wöchentlich

Ask Grumpy, a podcast featuring Steve Bender, AKA Southern Living’s Grumpy Gardener is back for Season 3. For more than 30 years, Grumpy has been sharing advice on what to grow, when to plant, and how to manage just about anything in your garden. Tune in for short episodes every Wednesday and Saturday as Grumpy answers reader questions, solves seasonal conundrums, and provides need-to-know advice for gardeners with his very Grumpy sense of humor. Be sure to follow Ask Grumpy wherever you listen so you don't miss an episode.

EMJ GOLD: Pharma marketing, medical & more

Teilen

Serie-Home•Feed

Inhalt bereitgestellt von Alice Watson. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Alice Watson oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm. Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.

… continue reading

294 Episoden

#Business #Alice Watson #Marketing #Medicalaffairs #Pharma #Pharmaceuticalinnovation #Pharmainnovation #Pharmatech #Podcasting Education #Patientcentric #Pharmaceutical

Artwork

EMJ GOLD: Pharma marketing, medical & more

updated vor etwa einem Jahr

Teilen

Serie-Home•Feed

Inhalt bereitgestellt von Alice Watson. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Alice Watson oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm. Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.

… continue reading

294 Episoden

#Business #Alice Watson #Marketing #Medicalaffairs #Pharma #Pharmaceuticalinnovation #Pharmainnovation #Pharmatech #Podcasting Education #Patientcentric #Pharmaceutical

Tous les épisodes

×

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S09E10: Galen’s Dr Dennise Broderick on why kindness isn’t a weakness in business 30:07

vor 6 weeks30:07

Später Spielen

Später Spielen

30:07

Join Isabel and Jade as they wrap up Season 9 of the podcast with special guest Dennise Broderick, President and Managing Director, Galen Pharma. In this episode, Jade and Dennise discuss her move from academia to the pharmaceutical industry, her lifelong ambition to be a leader and how she approaches hard decisions in business. A little more on EMJ GOLD’s guest… Dennise is Managing Director and President at Galen – a pharmaceutical company based in Northern Ireland focused on pain management, dermatology and gastroenterology. There, she is responsible for all the aspects of the company’s operations, marketing and governance across its various sites throughout the UK and Europe. Previously, Dennise has held positions at Pfizer, Hospira, Zeneus and Viatris – most recently working as the Country Manager at Ipsen.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S09 E09: Boehringer’s Christoph von der Goltz on setbacks and success in R&D 22:08

vor 7 weeks22:08

Später Spielen

Später Spielen

22:08

How can pharmaceutical companies best navigate setbacks in drug development to deliver breakthroughs in R&D? Find out in this week’s episode, where Isabel and Jade share an interview with Christoph von der Goltz, Global Head of Medicine Central Nervous System and Emerging Areas, Boehringer Ingelheim. Together, he and Jade explore the ins and outs of drug failure, whether to pivot or persevere after an R&D setback, how to better break the stigma of mental illness and much more. A little more on EMJ GOLD’s guest… Christoph von der Goltz is Global Head of Medicine Central Nervous System and Emerging Areas at Boehringer Ingelheim. He has more than 15 years of experience in a variety of roles in pharmaceutical R&D. He is also a board-certified psychiatrist with more than 10 years of clinical experience in neurology and psychiatry and academic research in preclinical, clinical and public health projects in Germany and Sweden.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S09 E08: HBA STAR Rebecca Vermeulen on purpose, passion and patients 32:05

vor 7 weeks32:05

Später Spielen

Später Spielen

32:05

Join Isabel and Jade this week as they delve into lessons in leadership and patient centricity with Rebecca Vermeulen, recipient of the Healthcare Businesswomen's Association (HBA) STAR award for 2025. Rebecca shares her journey from pharmacist to industry leader, discussing her approach to leadership, the current landscape for women in pharma and what effective patient centricity looks like in practice. A little more on EMJ GOLD’s guest Rebecca was recently awarded the STAR prize by the Healthcare Businesswomen’s Association in recognition of her outstanding contributions to the organisation’s growth, influence and impact. Her win highlights her leadership, particularly during her time as the HBA Global Board Chair throughout the pandemic. She has spent over 30 years working in the industry and has served in a variety of functions including medical affairs, clinical research, sales and medical communications.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S09 E07: DeepHealth’s Naiara Martínez Cabrera on AI’s role in radiology 19:18

vor 9 weeks19:18

Später Spielen

Später Spielen

19:18

Join Isabel and Jade as they uncover how AI is shaking up the radiology space and beyond with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth. Together, Naiara and Jade explore what first drew the marketing leader to the healthcare sector, why radiology in particular has seen such a boost from artificial intelligence, what other therapy areas can learn from space and much more. A little more on EMJ GOLD’s guest… Naiara Martínez Cabrera is Vice President of Global Marketing, DeepHealth, where she has been since the company’s inception in 2023. Prior to this appointment, she worked at Philips in roles such as Head of Communications and Head of Downstream Marketing for Precision Diagnosis.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S09 E06: Boston Scientific’s Angelo Auricchio on what’s next for heart health 33:25

vor 11 weeks33:25

Später Spielen

Später Spielen

33:25

This week, join Isabel and Jade as they explore what’s on the horizon for cardiac care, focusing on the revolutionary impact of remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific. He and Isabel discuss Angelo’s recent career change into the industry, how technology could reform the UK’s NHS, the role of remote monitoring in patient wellbeing and more. A little more on EMJ GOLD’s guest… Angelo Auricchio was appointed Chief Medical Officer, Rhythm Management, Boston Scientific in September 2024, where he works across the EMEA region. Prior to his time in industry, he gained a wealth of experience in academia and medicine, serving as Editor-in-Chief of the European Society of Cardiology’s journal EP Europace and President of the European Heart Rhythm Association. During his time in the medical field, he also served as Deputy Head of the Cardiology Department and Director of the Clinical Electrophysiology Unit at the Istituto Cardiocentro Ticino in Switzerland.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S09 E05: The HBA’s Mary Stutts on tackling bias for better women’s health 36:40

vor 12 weeks36:40

Später Spielen

Später Spielen

36:40

Join Isabel and Jade as they explore the persistent misunderstandings of women’s health in modern medicine with Mary Stutts, CEO of the Healthcare Businesswomen’s Association. In this episode, Mary unpacks the key findings of the HBA’s latest report, which exposes critical gaps in doctors’ understanding of women’s health. She discusses the root causes, the real-world consequences and what the pharmaceutical industry must do to drive meaningful change. A little more on EMJ GOLD’s guest… Mary is the CEO of the HBA, a global organisation with a mission is to promote the advancement and impact of women in healthcare. She is a leading voice in the industry, advocating for inclusive leadership, representative workforces and health equity. Prior to joining the HBA, she worked for Genentech, Bristol Myers Squibb, Bayer and other pharmaceutical organisations. She is also an accomplished author, having published her books ‘Recurring Themes of Exclusion in the Workplace’ and ‘The Missing Mentor: Women Advising Women on Power, Progress and Priorities’.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S09 E04: Does interactivity boost memory, recall and retention? 9:47

vor 13 weeks9:47

Später Spielen

Später Spielen

9:47

Why do we forget? Join Isabel and Jade as they explore the science behind memory, recall and retention, and uncover why interactive content could be the key to making information stick. In this episode, discover how interactivity enhances learning, helps HCPs recognise the value of new therapies and ultimately improves patient care. Read our article exploring the topic further here . And if you’re interested to see how interactive works in the medical context, check out the interactive article mentioned here .…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S09 E03: J&J’s Martin Price on World Cancer Day 2025 – Part 2 22:15

vor 14 weeks22:15

Später Spielen

Später Spielen

22:15

Join Isabel and Jade for part two of their World Cancer Day special for 2025, where guest Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson, uncovers more of his insights into the oncology space. In this instalment, Martin shares his thoughts on improving access to innovative cancer medicines, improving public trust toward the industry and his personal leadership style. A little more on GOLD’s guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in Europe, the Middle East and Africa, Johnson & Johnson, a role he has held for the past eight years. He leads the teams responsible for achieving optimal and accelerated market access, at a fair and value-based price, for Johnson & Johnson’s new products and indications. Prior to this, Price worked in Johnson & Johnson’s UK affiliate, latterly as director of external affairs, where he was responsible for market access, communications and government affairs. He joined Johnson & Johnson in 2001 from GlaxoSmithKline, where he began his career as senior health-outcomes manager.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S09 E02: J&J's Martin Price on World Cancer Day 17:36

vor 15 weeks17:36

Später Spielen

Später Spielen

17:36

Join Isabel and Jade as they present a special World Cancer Day 2025 edition of the podcast. They are joined by Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson. In this first instalment of the conversation, Martin and Jade discuss this year’s theme ‘United by Unique’, the increasing importance of real-world evidence in oncology and improving access to innovative cancer medicines. A little more on GOLD’s guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in Europe, the Middle East and Africa, Johnson & Johnson, a role he has held for the past eight years. He leads the teams responsible for achieving optimal and accelerated market access, at a fair and value-based price, for Johnson & Johnson’s new products and indications. Prior to this, Price worked in Johnson & Johnson’s UK affiliate, latterly as director of external affairs, where he was responsible for market access, communications and government affairs. He joined Johnson & Johnson in 2001 from GlaxoSmithKline, where he began his career as senior health-outcomes manager.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S09 E01: Lundbeck’s Charl van Zyl on a new era in neurology 22:23

vor 16 weeks22:23

Später Spielen

Später Spielen

22:23

The EMJ GOLD podcast is back for a new season! In the first episode of Season 9, the team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders, making this the 'decade of the brain', and how industry can do more to support patients living brain conditions. Together, Charl and Isabel explore his career journey in the pharmaceutical industry, Lundbeck’s plans for the future, the role of digital health technology and much more. A little more on EMJ GOLD’s guest... Charl van Zyl joined Lundbeck as President and CEO in September 2023. He brings more than 23 years of experience from commercial international management roles within the pharmaceutical industry, most recently in the field of immunology and neurology from UCB where he served as Executive Vice President and Head of Neurology globally, responsible for corporate activities in Europe and international markets. Charl is British and holds a degree in Medical Biochemistry from the University of Cape Town, South Africa. He has lived and worked in South Africa, United States, Japan, Switzerland, Belgium and now Denmark.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
The 2025 pharma forecast 20:15

vor 16 weeks20:15

Später Spielen

Später Spielen

20:15

Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year’s predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead. The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ’s own Dr Jonathan Sackier - all of whom share their predictions in their areas of expertise. A little more on GOLD’s guests… Jennifer Schranz is the Senior Vice President, Global Head of Rare Diseases at Ipsen, where she oversees the Rare Diseases therapy area with a focus on R&D strategy and execution. During her time at the business, she has led talented teams of scientists and fostered strong internal collaborations within the company, leveraging her clinical development expertise to advance Ipsen’s vision of addressing challenging rare diseases. Mercedes Diz has over 20 years’ experience in the pharmaceutical industry, having graduated with a degree in Biochemistry and Molecular Biology from the Autonomous University of Madrid. She has worked in a number of different pharmaceutical companies, from J&J to Pfizer, and is also a keen member of the Healthcare Businesswomen’s Association. At Almirall, she leads portfolio strategy and commercial innovation for global brands, new products and digital and cultural transformation. Dr Jonathan Sackier is Chairman at EMJ and the host of the EMJ podcast, where he utilises his experience as a physician to discuss the latest breakthroughs and challenges in the medical field with fellow practitioners and experts. Jonathan is a founding partner of many start-ups in the medical technology space and created the world’s first operating room robot.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
Bonus episode: Pharma review of the year 2024 23:43

vor 21 weeks23:43

Später Spielen

Später Spielen

23:43

As 2024 comes to a close, it's time to look back on a year in the pharmaceutical industry. In this final episode of the year, Isabel and Jade are joined by three former guest to reflect on the pivotal moments that defined the past 12 months. They are joined by Jennifer Schranz from Ipsen, Martina Dempsey from Astellas and Elias Revonta, CEO of Orcason, who all return to the podcast to share their insights. Together, they’ll discuss the major trends, challenges and breakthroughs that shaped 2024, including advancements in oncology, gene therapy, rare diseases and the growing role of AI. A little more on EMJ GOLD's guests... Jennifer Schranz is the Senior Vice President, Global Head of Rare Diseases at Ipsen, where she oversees the Rare Diseases therapy area with a focus on R&D strategy and execution. During her time at the business she has led talented teams of scientists and fostered strong internal collaborations within the company, leveraging her clinical development expertise to advance Ipsen’s vision of addressing challenging rare diseases. Martina Dempsey is the Vice President of Commercial Strategy & Operations at Astellas Europe, having worked with the business since 2014 in her home country of Ireland. In addition to her role at the pharma company, she also acts as a Board Member for the Irish Pharmaceutical Healthcare Association. Prior to her time at Astellas, she spent 13 years at GSK in various roles including in the regulatory affairs and business transformation sectors. Elias Revonta is the Founder and CEO, Orcason Medical, where he is supported by a strong background in the medical device industry – spanning over 20 years in various leadership roles from sales to product development. He is passionate about transforming and democratising healthcare with modern and easy-to-use diagnostic tools that serve all demographics.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S08 E10: Bayer’s Dr Cecilia Caetano on making space for menopause 26:56

vor 23 weeks26:56

Später Spielen

Später Spielen

26:56

In this final episode of the season, Isabel discusses how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Head, Global Medical Affairs, Women’s Health, Bayer. Menopause affects over 50% of the world’s population, but its symptoms and effects are often misunderstood or ignored. Find out how industry can help by equipping not only HCPs but also women with the knowledge and awareness to manage menopause on an individual level, debunking the myths and prejudices surrounding the topic and much more.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
Season 8 highlights: GOLD Medal Moments 13:06

vor 24 weeks13:06

Später Spielen

Später Spielen

13:06

Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the last couple of months? From an insight into why Gen Z might be turning their sails towards the pharmaceutical industry, to a call for a better understanding of HIV stigma, there’s plenty to discover in this season’s GOLD Medal Moments.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S08 E09: World AMR Awareness Week with Orcason Medical’s Elias Revonta 24:23

vor 25 weeks24:23

Später Spielen

Später Spielen

24:23

In this episode of the EMJ GOLD podcast, Jade and Isabel explore one of the most urgent global health issues: antimicrobial resistance (AMR). As part of World AMR Awareness Week, they are highlighting this year’s theme ‘Educate. Advocate. Act now’. Joining the conversation is Elias Revonta, Founder and CEO, Orcason Medical, who shares his vision for tackling AMR through groundbreaking medical technology. Orcason Medical is pioneering point-of-care devices for ear, nose and throat conditions to address the overprescription of antibiotics—a vital measure in the fight against AMR. A little more on GOLD’s guest… Elias Revonta is the Founder and CEO, Orcason Medical, where he is supported by a strong background in the medical device industry – spanning over 20 years in various leadership roles from sales to product development. He is passionate about transforming and democratising healthcare with modern and easy-to-use diagnostic tools that serve all demographics. With a mission to combat the rise of AMR, his goal is to protect the power of antibiotics and improve the lives of millions of patients by enabling smarter, safer healthcare solutions.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S08 E08: Alfasigma’s Patrick Oliver on the company’s new chapter in the UK 20:31

vor 26 weeks20:31

Später Spielen

Später Spielen

20:31

In this episode, Isabel welcomes Patrick Oliver, General Manager for the UK and Ireland at Alfasigma, to explore the company’s exciting entry into the UK market and the evolving landscape of healthcare in the country. In the conversation, Patrick brings his wealth of industry experience to share his vision for Alfasigma’s future, the potential he sees in the UK healthcare market and the unique challenges ahead. They also delve into Lord Darzi’s report on the NHS, examining its implications for healthcare reform and innovation. A little more on GOLD’s guest… Patrick Oliver is Alfasigma’s General Manager for the UK & Ireland, a role he’s held since the company’s launch in the UK in early 2024. He has 36 years’ experience in the industry, with 16 years specifically in market access. Prior to joining Alfasigma, Patrick worked in market access for a number of large pharmaceutical companies including Johnson & Johnson, AbbVie and Abbott.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S08 E07: What should marketing and medical affairs invest in for Q4? 9:17

vor 27 weeks9:17

Später Spielen

Später Spielen

9:17

As 2024 draws to a close, what should pharma teams be focusing their budgets on for the final quarter of the year? Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024. As teams finalise their budgets and plan for the final quarter and year ahead, this conversation brings insights into how strategies like personalised engagement, thought leadership and interactive, on-demand content are making an impact. With real-life examples, learn about the tools you can invest in to end the year on a high.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S08 E06: Ipsen’s Jennifer Schranz on rethinking rare disease for women 23:41

vor 29 weeks23:41

Später Spielen

Später Spielen

23:41

In this new episode, the team welcomes Jennifer Schranz, Senior Vice President, Global Head of Rare Diseases, Ipsen, to investigate the burden faced by women with rare diseases. Together, Jennifer and Jade discuss how the industry can address challenging rare diseases and making a meaningful impact on patients’ lives, the double jeopardy that women with rare diseases face, recent breakthroughs in the space and much more.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S08 E05: ARS' Richard Lowenthal on his mission to transform allergy care 21:04

vor 30 weeks21:04

Später Spielen

Später Spielen

21:04

In the latest episode of our podcast, we welcome Richard Lowenthal, CEO, ARS Pharmaceuticals, to explore the company’s mission to address unmet needs in allergy care. During the conversation, Richard shares insights into his early career at the FDA and the regulatory challenges he faced in bringing ARS’s new nasal spray to treat severe allergic reactions to market. He also discusses the future direction of the company and much more. A little more on EMJ GOLD’s guest… Richard Lowenthal is the co-founder, President, and CEO, ARS Pharmaceuticals, with a leadership role since the company’s inception in 2015. Before ARS, he founded Pacific-Link Regulatory Consulting, where he contributed to the development of their diazepam nasal spray. Richard’s extensive background includes senior roles at Cadence Pharmaceuticals, Maxim Pharmaceuticals and Janssen Research Foundation, as well as work as a chemist at the FDA. He holds an M.Sc. in organic chemistry and an MSEL and has chaired the American Association of Pharmaceutical Scientists.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S08 E04: Astellas’ Martina Dempsey on achieving equal footing for women in pharma 29:07

vor 31 weeks29:07

Später Spielen

Später Spielen

29:07

In the latest episode, Jade sits down with Martina Dempsey, Vice President of Commercial Strategy and Operations at Astellas Europe, to discuss empowering women in the pharmaceutical industry. They explore how pharma meets the needs and values of young graduates, the ongoing challenges women face in securing leadership roles, the critical impact of mentorship on career development and much more.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S08 E03: World Mental Health Day with Boehringer Ingelheim’s Nedim Pipic 24:24

vor 32 weeks24:24

Später Spielen

Später Spielen

24:24

In this episode, Isabel is joined by Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim, to mark World Mental Health Day on 10 October 2024. Their conversation dives into the unique challenges faced by those living with serious mental illnesses, the impact of media representation and the role pharma can play in transforming treatment and quality of life for these patients. Central to their discussion is the importance of amplifying lived experiences, a key focus of Boehringer’s new campaign, Schizophrenia in Real Life: Stories of Challenges, Resilience, and Hope . The campaign aims to build greater understanding and acceptance of the condition by highlighting the strength and resilience of those living with it.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S08 E02: ViiV Healthcare’s Jean-Bernard Simeon on ending the HIV epidemic 27:41

vor 33 weeks27:41

Später Spielen

Später Spielen

27:41

This week, Jean-Bernard Simeon, Senior Vice President and Head, ViiV Healthcare Europe, sits down with the EMJ GOLD team to share his thoughts on the current landscape for patients with HIV in Europe. Together, JB and Jade explore the UNAIDS roadmap to end the HIV epidemic by 2030, the barriers faced by people living with HIV in Europe, stigmas still surrounding the condition and much more.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S08 E01: Moderna’s Chantal Friebertshäuser on improving vaccine confidence 25:48

vor 34 weeks25:48

Später Spielen

Später Spielen

25:48

The EMJ GOLD podcast is back! In the first episode of season 8, Jade sits down with Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna, to discuss how Europe can combat the recent erosion of trust in vaccines. Together, the two explore the role of governments in addressing vaccine hesitancy, improving vaccine education amongst various groups, how a culture of collaboration can improve the current vaccine landscape and much more.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
Season 7 highlights: GOLD Medal Moments 11:55

vor 36 weeks11:55

Später Spielen

Später Spielen

11:55

The new season of the podcast is only a week away, so before we get started – why not have a listen to some of the best bits from Series 7? From a deep dive into women’s health to why the industry thrives on a little healthy competition, there’s plenty to discover in last season’s highlights. As well as the EMJ GOLD team’s analysis of the key themes, you’ll hear from six former guests: Mercedes Diz , Chief Marketing Office, Almirall Nichole Davies, Global Chief Strategy Officer, VML Health Edmond Chan , Senior Director, EMEA TA Lead, Haemato-Oncology, J&J Stefan Woxström , Senior Vice President, Europe and Canada, AstraZeneca Danie Du Plessis , EVP, Pharmaceutical Operations, Kyowa Kirin Harmony Garges , Chief Medical Officer ViiV Healthcare.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S07 E10: Astellas’ Tadaaki Taniguchi on how to challenge the status quo 28:43

vor 40 weeks28:43

Später Spielen

Später Spielen

28:43

In this season finale of the EMJ GOLD podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma, about how he strives to challenge the status quo in the pharmaceutical industry. The two discuss how Tadaaki’s time as a surgical oncologist has influenced his leadership style, how collaboration is key for making impacts for patients, the next game changers in cancer treatment and more. A little bit more on EMJ GOLD’s guest… Dr Tadaaki Taniguchi leads Astellas’ global team in identifying, discovering and developing new treatments that have the potential to transform healthcare, with a focus on innovative and patient-centred therapies. He has more than 20 years of industry experience spanning research, development and medical affairs, and has worked in a range of therapeutic areas including diabetes and oncology. Prior to joining Astellas, Tadaaki held senior positions at other major pharmaceutical companies in the US, Japan and China. Before joining the industry, he spent 10 years as a surgical oncologist – giving him a unique perspective on how to deliver breakthrough science that changes the way diseases are treated.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S07 E09: Taking control of customer experience 10:55

vor 41 weeks10:55

Später Spielen

Später Spielen

10:55

In this penultimate episode of Season 7, Isabel and Jade sit down to discuss EMJ GOLD’s most recent features of the month – our infographic on optimising pharma’s customer experience journey and an article on how exactly to design this experience. Within the episode, the team explore how the industry may be missing out on insights gathered from HCPs, what makes a ‘winning’ website for HCPs and more – featuring exclusive input from Robert Tegge, Associate Principal, ZS, who shares valuable insights on what HCPs are really looking for before and after a congress. A little more on EMJ GOLD’s guest… Robert Tegge is a leader within the ZS meetings and events practice area, which focuses on identifying insights to drive improved outcomes for our clients’ meetings programs. He collaborates with organizations to help build capabilities and solve unique problems, leveraging ZS’s technology and operations infrastructure as well as industry expertise. Robert has a wealth of experience in strategy and operations roles across various healthcare sectors, including providers, pharmaceuticals, and medical products. In these roles, he has consistently leveraged data to provide actionable insights on a variety of sales, marketing, and growth decisions. He also holds a B.S. and an M.S. in civil engineering from the University of Illinois at Urbana-Champaign, and an MBA from Northwestern University’s Kellogg School of Management.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S07 E08: ViiV Healthcare’s Harmony Garges on giving voice to people with HIV 15:32

vor 42 weeks15:32

Später Spielen

Später Spielen

15:32

In this week’s edition of the podcast, Isabel and Jade share an interview with Dr Harmony Garges, Chief Medical Officer, ViiV Healthcare. She speaks with Dr Jonathan Sackier, Host, EMJ Podcast, who joined us in Reuters Barcelona where we meet our guest. Together, the two discuss Harmony’s decision to join the pharmaceutical industry, how treating children with HIV needs to be approached differently, her views on improving vital access to HIV treatment and much more. This is the longer version of her Catalyst interview with us, check that out here .…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S07 E07: Kyowa Kirin’s Danie du Plessis on the potential of patient partnerships 29:35

vor 43 weeks29:35

Später Spielen

Später Spielen

29:35

In this week’s episode, Danie du Plessis, Executive Vice President, Pharmaceutical Operations, Kyowa Kirin, sits down with the EMJ GOLD team to share the value that patient partnerships can hold in the industry. Danie explores how patient partnerships have evolved over the years, what companies should be doing to get them to their best potential, the value of learning from others and much more. A little more on EMJ GOLD’s guest… After completing his medical studies and a Master’s Degree in Clinical Pharmacology in South Africa, Danie spent three years working in a primary care setting including his own private practice. He joined the pharmaceutical industry in 1993, worked in medical affairs, marketing and sales, pharmacovigilance and clinical operations. He has held roles such as including Senior Vice President and Head of Worldwide Medical Affairs at GlaxoSmithKline. Danie joined Kyowa Kirin International in August 2019 as head of Medical Affairs and has been Executive Vice President Pharmaceutical Operations since April 2024. He is also a Director and Chair of the Global non-profit Medical Affairs Professional Society (MAPS) Board, Fellow of the Faculty of Pharmaceutical Medicine in the UK, visiting senior lecturer at King’s College, London and an affiliate member of the Association for Professional Executive Coaching and Supervision (APECS).…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S07 E06: AZ’s Stefan Woxström on why without health, we don’t have anything 40:41

vor 44 weeks40:41

Später Spielen

Später Spielen

40:41

Tune in to the latest episode of the EMJ GOLD podcast as Isabel and Jade cross the halfway point of the season with special guest host Dr Jonathan Sackier of the EMJ podcast. In this episode, the team listen back to Jonathan's discussion with Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca at Reuters Events: Pharma 2024 in Barcelona. Together, the two unpick the current small molecule funding landscape, how to improve incentives to invest in rare diseases, how to better inform policymakers about the difference they can make and much more. A little more on EMJ GOLD’s guest… In Stefan’s role as SVP Europe and Canada at AstraZeneca, he is dedicated to supporting teams across 30 markets to grow the company ethically and sustainably. His focus is to improve the lives of millions of patients, with a particular emphasis on partnering to find solutions to healthcare challenges, addressing the burden of chronic disease and transforming health systems to be more future-proofed and resilient. He’s worked at AstraZeneca for over 28 years, having joined before the merger of Astra and Zeneca in 1999, and holds a BSc and MSc in Business Administration & Economics from Stockholm University. He has additionally sat on the boards of multiple corporations, including The Swedish Chamber of Commerce and Industry in Japan, the EFPIA and most recently the Swedish Swiss Chamber of Commerce.…

E

EMJ GOLD: Pharma marketing, medical & more

EMJ GOLD: Pharma marketing, medical & more podcast artwork

1
S07 E05: Sandoz’s Claire D’Abreu-Hayling on leading with love 19:54

vor 45 weeks19:54

Später Spielen

Später Spielen

19:54

This week, Claire D'Abreu-Hayling, Chief Scientific Officer, Sandoz, joins Isabel on the podcast to share how leading with love rather than ruling with an iron fist is the best way to get results in the pharmaceutical industry. In this episode, Claire and Isabel discuss how she fell in love with science as a child, the leadership skills she has gained over the course of her career and the importance of valuing your people and being valued in return. A little more on EMJ GOLD’s guest… Claire D'Abreu-Hayling is the Chief Scientific Officer at Sandoz, and with more than 30 years of experience in the pharmaceutical industry under her belt, she knows a thing or two about life sciences leadership - past and present. At the company Claire oversees the global product development network where she manages infrastructure strategy, pipeline execution and talent acquisition for both small molecules and biosimilars. Outside of work, Claire is a true champion of authenticity in the workplace. She is passionate about diversity, equity and inclusion and is particularly committed to mentoring Black and Asian women who are pursuing careers in STEM.…

Willkommen auf Player FM!

Player FM scannt gerade das Web nach Podcasts mit hoher Qualität, die du genießen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos geräteübergreifend zu synchronisieren.

Höre 500+ Themen zu

Hören Sie sich diese Show an, während Sie die Gegend erkunden